Hypersensitivity syndrome caused by amitriptyline administration

Adverse cutaneous manifestations are among the most common side effects associated with psychotropic drugs. Skin reactions due to amitriptyline (a tricyclic antidepressant agent) include rashes and hypersensitivity reactions (for example, urticaria and photosensitivity) as well as hyperpigmentation. Hypersensitivity syndrome is a specific severe idiosyncratic reaction causing skin, liver, joint, and haematological abnormalities, which usually resolve after the discontinuation of the implicated drug. A case of a 24 year old woman who experienced hypersensitivity syndrome three weeks after the initiation of amitriptyline is reported.

[1]  J. Muglia,et al.  Anticonvulsant hypersensitivity syndrome. , 1995, Archives of internal medicine.

[2]  C. Brander,et al.  Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. , 1995, Journal of immunology.

[3]  L. Hughes-Davies,et al.  Severe adverse cutaneous reactions to drugs. , 1995, The New England journal of medicine.

[4]  B. Strom,et al.  A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. , 1991, Archives of dermatology.

[5]  Jeffrey D. Miller,et al.  Suppression of carbamazepine‐induced rash with prednisone expedited publication , 1991, Neurology.

[6]  J. D. Miller,et al.  Suppression of carbamazepine-induced rash with prednisone. , 1991, Neurology.

[7]  M. Davis.  Hepatotoxicity of antidepressants. , 1991, International clinical psychopharmacology.

[8]  A. Srebrnik,et al.  Adverse cutaneous reactions to psychotropic drugs. , 1991, Acta dermato-venereologica. Supplementum.

[9]  M. Boggild,et al.  Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure , 1989, Neurology.

[10]  S. Spielberg,et al.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. , 1988, The Journal of clinical investigation.

[11]  S. Spielberg,et al.  In Vitro Assessment of Risk , 1988 .

[12]  R. S. Basler,et al.  Synergism of minocycline and amitriptyline in cutaneous hyperpigmentation. , 1985, Journal of the American Academy of Dermatology.